AroraSPanaichSPatelN. Multi-vessel percutaneous coronary interventions in the US: Insights from the nationwide inpatient sample. Angiology. 2016;67(4):326–335. doi:10.1177/0003319715593853
2.
NabelEGBraunwaldE. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012;366(1):54–63.
3.
StefaniniGGHolmesDRJr. Drug-eluting coronary-artery stents. N Engl J Med. 2013;368(3):254–265.
4.
MeierP. Bioabsorbable drug eluting stent: Winner or sinner?BMJ. 2013;347:f7091.
5.
MaronDJBodenWEO’RourkeRA. Intensive multifactorial intervention for stable coronary artery disease: Optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. J Am Coll Cardiol. 2010;55(13):1348–1358.
6.
BodenWEO’RourkeRATeoKK. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–1516.
7.
DouglasPSHoffmannUPatelMR. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372(14):1291–1300.
8.
EskolaMJHolmvangLNikusKC. The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: Correlation with therapeutic approach, coronary anatomy, and outcome in the DANAMI-2 trial. Eur Heart J. 2007;28(24):2985–2991.
9.
BuskMMaengMRasmussenK. The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. Eur Heart J. 2008;29(10):1259–1266.
10.
PalmeriniTBiondi-ZoccaiGDella RivaD. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2013;62(6):496–504.
11.
KowalewskiMSchulzeVBertiS. Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials. Heart. 2015;101(16):1309–1317. doi:10.1136/heartjnl-2014-307293
12.
KingSBIIIKosinskiASGuytonRALemboNJWeintraubWS. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 2000;35(5):1116–1121.
13.
HannanELRaczMJWalfordG. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352(21):2174–2183.
14.
VelazquezEJLeeKLDejaMA. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607–1616.
15.
SianosGMorelMAKappeteinAP. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–227.
16.
SerruysPWMoriceMCKappeteinAP. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–972.
17.
MohrFWMoriceMCKappeteinAP. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629–638.
18.
ChanPSPatelMRKleinLW. Appropriateness of percutaneous coronary intervention. JAMA. 2011;306(1):53–61.
AthyrosVGTziomalosKFlorentinMKaragiannisAMikhailidisDP. Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: A new pleiotropic effect?Curr Med Res Opin. 2010;26(4):839–842.
23.
KatsikiNAthyrosVGMikhailidisDP. Does metabolic syndrome influence outcome following percutaneous coronary intervention?Angiology. 2011;62(6):437–439.
24.
FarkouhMEDomanskiMSleeperLA. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375–2384.
25.
FanariZWeissSAZhangWSonnadSSWeintraubWS. Short, intermediate and long term outcomes of CABG vs. PCI with DES in patients with multivessel coronary artery disease. Meta-analysis of six randomized controlled trials. Eur J Cardiovasc Med. 2014;3(1):382–389.
26.
SmitYVlayenJKoppenaalHEeftingFKappeteinAPMarianiMA. Percutaneous coronary intervention versus coronary artery bypass grafting: A meta-analysis. J Thorac Cardiovasc Surg. 2015;149(3):831–838. e831–e813.
27.
ParkSJAhnJMKimYH. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med. 2015;372(13):1204–1212.
28.
BangaloreSGuoYSamadashviliZBleckerSXuJHannanEL. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med. 2015;372(13):1213–1222.
29.
ZhuPZhouPSunYGuoYMaiMZhengS. Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: systematic review and meta-analysis. J Cardiothorac Surg. 2015;10(1):63.
